VSDTHE SEMAGLUTIDE FILE

A plain-language guide to virtual care

Open guide.

QUESTION BRIEF · GENERIC OR NOT

Is compounded semaglutide just generic Ozempic?

MYTH.A cheaper semaglutide offer is simply generic Ozempic.

FACT.In September 2026, no generic semaglutide with FDA approval could be marketed in the United States. A compounded preparation is not an approved generic drug.

The label may use the same ingredient word. The product can still be different. Same does not mean generic. Names can fool us. Records give the answer. Ask what is in the box. Ask who made it. Ask which public record covers it. Read the full name. Write it down. Check it once. Do not fill in a gap. Get the record. Use the exact words. If the answer is vague, pause.

The names are doing different jobs

As of September 2026, semaglutide is the ingredient name. Ozempic, Rybelsus and Wegovy are approved product names.

An FDA-approved generic has its own approved application. A compound is made through the pharmacy-compounding route.

Tentative does not mean available

As of September 2026, one semaglutide generic application had tentative FDA approval, which means it could not yet be marketed.

Words such as “generic” and “same active ingredient” are not enough. Ask for the exact product name, who made it (the drug company, or the pharmacy that mixed it), and which kind it is: FDA-approved, compounded, or not approved at all.

Check the chemical name too

As of September 2026, the FDA said some products used other chemical forms of semaglutide, called salts, such as semaglutide sodium and semaglutide acetate. The FDA counts these as different ingredients from the one in approved semaglutide drugs.

As of September 2026, the FDA said it knew of no legal way for a pharmacy to use those salt forms.

The invoice or ingredient record can answer a question that glossy copy avoids: does another word appear after “semaglutide”?

ANNOTATED READING LIST

Evidence, with a note on why it belongs

  1. Official semaglutide application records.The FDA’s own record of which drugs are approved, and which are only “tentatively” approved and not yet allowed on sale.
  2. Official concerns about pharmacy-made weight medicines.The FDA discusses salt forms, fake labels and the risks of pharmacy-mixed GLP-1 drugs, the family of weight medicines semaglutide belongs to.